HeartMate left ventricular assist device as bridge to heart transplantation

被引:35
作者
Koul, B [1 ]
Solem, JO
Steen, S
Casimir-Ahn, H
Granfeldt, H
Lönn, UJ
机构
[1] Univ Lund Hosp, Dept Cardiovasc & Thorac Surg, S-22185 Lund, Sweden
[2] Linkoping Univ Hosp, Dept Thorac & Cardiovasc Surg, S-58185 Linkoping, Sweden
关键词
D O I
10.1016/S0003-4975(98)00224-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Because of the limited supply of donor hearts, prospective recipients continue to die while on the waiting list for heart transplantation. Use of longterm mechanical circulatory support devices as a bridge to transplantation may reduce this mortality. However, with the present state of technology, continued clinical evaluation of the various long-term, mechanical circulatory support devices available is mandatory. Methods. Sixteen patients were bridged with the HeartMate left ventricular assist device (LVAD) to heart transplantation for New York Heart Association functional class IV cardiac failure. Twelve pneumatic and six electric devices were used. The mean cardiac index and the mean pulmonary vascular resistance of the patient cohort were 1.71.min(-1).m(-2) and 3.1 Wood units, respectively. Results. The mean LVAD support time per transplanted patient was 237 days, with a cumulative LVAD support time of about 7.2 years. Bleeding was the main operative and postoperative complication. Two patients suffered from neurologic complications and there were two major incidents of device malfunction. Twelve patients (75%) now have received a transplant, 3 (19%) ire awaiting a transplant, and in 1 patient (6%), the device was explanted after spontaneous left ventricular recovery. Eleven of the 12 patients who received a transplant are alive and doing well. The HeartMate LVAD gave adequate circulatory support over extended periods of time and reversed the vital organ dysfunction. Since the start of the LVAD program, only 1 patient has died on our heart transplantation waiting list, compared to nine deaths in the 2 preceding years. Conclusions. The HeartMate LVAD bridge to heart transplantation can be performed with low post-LVAD implantation and posttransplantation mortality and offers 1- and 2-year posttransplantation actuarial survival rates comparable to those for nonbridged heart transplant recipients. (C) 1998 by The Society of Thoracic Surgeons.
引用
收藏
页码:1625 / 1630
页数:6
相关论文
共 15 条
[1]   A RELIABLE BRIDGE TO CARDIAC TRANSPLANTATION - THE TCI LEFT-VENTRICULAR ASSIST DEVICE [J].
BURTON, NA ;
LEFRAK, EA ;
MACMANUS, Q ;
HILL, A ;
MARINO, JA ;
SPEIR, AM ;
AKL, BF ;
ALBUS, RA ;
MASSIMIANO, PS .
ANNALS OF THORACIC SURGERY, 1993, 55 (06) :1425-1431
[2]  
Copeland JG, 1996, J HEART LUNG TRANSPL, V15, P94
[3]  
DASSE K, 1996, 9 ANN HEARTM INV US
[4]   Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation [J].
Farrar, DJ ;
Hill, JD ;
Pennington, DG ;
McBride, LR ;
Holman, WL ;
Kormos, RL ;
Esmore, D ;
Gray, LA ;
Seifert, PE ;
Schoettle, GP ;
Moore, CH ;
Hendry, PJ ;
Bhayana, JN .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (01) :202-209
[5]   IMPROVED MORTALITY AND REHABILITATION OF TRANSPLANT CANDIDATES TREATED WITH A LONG-TERM IMPLANTABLE LEFT-VENTRICULAR ASSIST SYSTEM [J].
FRAZIER, OH ;
ROSE, EA ;
MCCARTHY, P ;
BURTON, NA ;
TECTOR, A ;
LEVIN, H ;
KAYNE, HL ;
POIRIER, VL ;
DASSE, KA .
ANNALS OF SURGERY, 1995, 222 (03) :327-338
[6]   MULTICENTER CLINICAL-EVALUATION OF THE HEARTMATE 1000-IP LEFT-VENTRICULAR ASSIST DEVICE [J].
FRAZIER, OH ;
ROSE, EA ;
MACMANUS, Q ;
BURTON, NA ;
LEFRAK, EA ;
POIRIER, VL ;
DASSE, KA .
ANNALS OF THORACIC SURGERY, 1992, 53 (06) :1080-1090
[7]   USE OF APROTININ IN LVAD RECIPIENTS REDUCES BLOOD-LOSS, BLOOD USE, AND PERIOPERATIVE MORTALITY [J].
GOLDSTEIN, DJ ;
SELDOMRIDGE, JA ;
CHEN, JM ;
CATANESE, KA ;
DEROSA, CM ;
WEINBERG, AD ;
SMITH, CR ;
ROSE, EA ;
LEVIN, HR ;
OZ, MC .
ANNALS OF THORACIC SURGERY, 1995, 59 (05) :1063-1068
[8]   STRATIFICATION OF MORBIDITY AND MORTALITY OUTCOME BY PREOPERATIVE RISK-FACTORS IN CORONARY-ARTERY BYPASS PATIENTS - A CLINICAL SEVERITY SCORE [J].
HIGGINS, TL ;
ESTAFANOUS, FG ;
LOOP, FD ;
BECK, GJ ;
BLUM, JM ;
PARANANDI, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (17) :2344-2348
[9]  
Hosenpud JD, 1996, J HEART LUNG TRANSPL, V15, P655
[10]  
JEEVANANDAM V, 1996, 9 ANN HEARTM INV US